Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs

Samankaltaisia teoksia

• Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs
  Tekijä: Hoshino, Yo, et al.
  Julkaistu: (2005)
• Protection from Herpes Simplex Virus (HSV) 2 Infection with Replication-Defective HSV-2 or Glycoprotein D2 Vaccines in HSV-1 Seropositive and Seronegative Guinea Pigs
  Tekijä: Hoshino, Yo, et al.
  Julkaistu: (2009)
• Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs
  Tekijä: Hoshino, Yo, et al.
  Julkaistu: (2008)
• Rates of Reactivation of Latent Herpes Simplex Virus from Mouse Trigeminal Ganglia Ex Vivo Correlate Directly with Viral Load and Inversely with Number of Infiltrating CD8(+) T Cells
  Tekijä: Hoshino, Yo, et al.
  Julkaistu: (2007)
• Glutamine supplementation suppresses herpes simplex virus reactivation
  Tekijä: Wang, Kening, et al.
  Julkaistu: (2017)